304 related articles for article (PubMed ID: 27026081)
21. IgG-F-actin antibodies in celiac disease and dermatitis herpetiformis.
Samaşca G; Băican A; Pop T; Pîrvan A; Miu N; Andreica M; Cristea V; Dejica D
Roum Arch Microbiol Immunol; 2010; 69(4):177-82. PubMed ID: 21462831
[TBL] [Abstract][Full Text] [Related]
22. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
[TBL] [Abstract][Full Text] [Related]
24. IgA-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: no evidence for gluten dependency.
Lindfors K; Koskinen O; Laurila K; Collin P; Saavalainen P; Haimila K; Partanen J; Mäki M; Kaukinen K
Clin Chim Acta; 2011 Jun; 412(13-14):1187-90. PubMed ID: 21453693
[TBL] [Abstract][Full Text] [Related]
25. Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease.
Kaunisto H; Salmi T; Lindfors K; Kemppainen E
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328331
[TBL] [Abstract][Full Text] [Related]
26. The Decreasing Prevalence of Severe Villous Atrophy in Dermatitis Herpetiformis: A 45-Year Experience in 393 Patients.
Mansikka E; Hervonen K; Salmi TT; Kautiainen H; Kaukinen K; Collin P; Reunala T
J Clin Gastroenterol; 2017 Mar; 51(3):235-239. PubMed ID: 27136959
[TBL] [Abstract][Full Text] [Related]
27. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and associated factors of abnormal liver values in children with celiac disease.
Äärelä L; Nurminen S; Kivelä L; Huhtala H; Mäki M; Viitasalo A; Kaukinen K; Lakka T; Kurppa K
Dig Liver Dis; 2016 Sep; 48(9):1023-9. PubMed ID: 27338852
[TBL] [Abstract][Full Text] [Related]
29. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
[TBL] [Abstract][Full Text] [Related]
30. IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients.
Borroni G; Biagi F; Ciocca O; Vassallo C; Carugno A; Cananzi R; Campanella J; Bianchi PI; Brazzelli V; Corazza GR
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):836-41. PubMed ID: 22672004
[TBL] [Abstract][Full Text] [Related]
31. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
[TBL] [Abstract][Full Text] [Related]
32. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.
Reunala T; Salmi TT; Hervonen K
Acta Derm Venereol; 2015 Nov; 95(8):917-22. PubMed ID: 26059085
[TBL] [Abstract][Full Text] [Related]
33. [Anti-transglutaminase antibody in adults with celiac disease and their relation to the presence and duration of gluten-free diet].
Ferreira S; Chamorro ME; Ortíz J; Carpinelli MM; Giménez V; Langjahr P
Rev Gastroenterol Peru; 2018; 38(3):228-233. PubMed ID: 30540725
[TBL] [Abstract][Full Text] [Related]
34. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
[TBL] [Abstract][Full Text] [Related]
35. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
[TBL] [Abstract][Full Text] [Related]
36. Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA.
Martín-Pagola A; Ortiz-Paranza L; Bilbao JR; de Nanclares GP; Estevez EP; Castaño L; Vitoria JC
Autoimmunity; 2007 Mar; 40(2):117-21. PubMed ID: 17364503
[TBL] [Abstract][Full Text] [Related]
37. Potential celiac children: 9-year follow-up on a gluten-containing diet.
Auricchio R; Tosco A; Piccolo E; Galatola M; Izzo V; Maglio M; Paparo F; Troncone R; Greco L
Am J Gastroenterol; 2014 Jun; 109(6):913-21. PubMed ID: 24777149
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
[TBL] [Abstract][Full Text] [Related]
39. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
[TBL] [Abstract][Full Text] [Related]
40. Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease.
Laass MW; Röber N; Range U; Noß L; Roggenbuck D; Conrad K
PLoS One; 2015; 10(6):e0128104. PubMed ID: 26047356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
